Active Biotech Q1’22: Our comments and updated valuation – Redeye Publicerad 22 apr 2022 kl 11.06 Redeye comments on Active Biotech’s first quarter report and updates its valuation and forecast.https://www.redeye.se/research/838916/active-biotech-q122-our-comments-and-updated-forecast?utm_source=finwire&utm_medium=RSSRedeye